July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Quality of vision after bilateral multifocal intraocular lens implantation in pregeriatric Hispanic population, after refractive lens exchange.
Author Affiliations & Notes
  • Jose Alberto Nava
    Instituto de Oftalmologia - Catarata, Tec de Monterrey, Monterrey, NUEVO LEON, Mexico
  • Nallely Rubi Morales-Mancillas
    Instituto de Oftalmologia - Catarata, Tec de Monterrey, Monterrey, NUEVO LEON, Mexico
  • Jorge E Valdez
    Instituto de Oftalmologia - Catarata, Tec de Monterrey, Monterrey, NUEVO LEON, Mexico
  • Footnotes
    Commercial Relationships   Jose Nava, None; Nallely Morales-Mancillas, None; Jorge Valdez, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 2063. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jose Alberto Nava, Nallely Rubi Morales-Mancillas, Jorge E Valdez; Quality of vision after bilateral multifocal intraocular lens implantation in pregeriatric Hispanic population, after refractive lens exchange.. Invest. Ophthalmol. Vis. Sci. 2019;60(9):2063.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The main limitations of multifocal IOLs are undesired visual effects and loss of contrast sensitivity. Dysphotopsia is commonly reported following multifocal intraocular lens implantation. A prospective study to analyze the phenomenon of dysphotopsia in patients implanted with five different multifocal IOL designs was performed.

Methods : Patients were recruited from the Institute of Ophthalmology at the Zambrano Hellion Medical Center / Tecnológico de Monterrey. Inclusion criteria for this study was patients who underwent sequential bilateral refractive lens exchange (RLE) who also were interested in presbyopia correction. Exclusion criteria were patients with any ocular pathology or previous surgery. A prospective study was performed in 73 eyes implanted with AcrySof IQ ReSTOR®, AcrySof IQ PanOptix®, FineVision®, Tecnis Symfony® and AT LISA® tri. Preoperative and postoperative visual acuities and refractive error were determined. Patient satisfaction in terms of dysphotopsia effects was assessed. Adverse events, including intraoperative and postoperative complications, also were evaluated.

Results : Seventy-three surgeries were performed in 37. These included 19 females (51.35%) and 18 males (48.64%). The mean age of the patients was 52.89 ± 3.99 years. No main comorbidities were associated. Mean preoperative uncorrected distance visual acuity UCDVA was 0.436 ± 0.20 Log MAR; mean postoperative UCDVA was 0.02 ± 0.05 Log MAR. No intraoperative complications were reported. All patients presented postoperative dysphotopsia effect. The mean days of symptomatology were: 23.6 (15-40) days with Alcon AcrySof® IQ ReSTOR®, 19.42 (7-30) days with Alcon AcrySof® IQ PanOptix®, 15.66 (7-45) days with PhysIOL FineVision®, 18.61 (7-60) days with Abbott Tecnis Symfony® and 25.72 (15-60) days with ZEISS AT LISA® tri. Posterior capsule opacification was reported in 2.7% of the patients.

Conclusions : Visual symptoms were similar after implantation of all different multifocal IOLs. The lowest average of days of dysphotopsia was achieved with PhysIOL FineVision®. After the second postoperative month symptomatology improved in all cases. These IOLs produced high levels of spectacle independence and patient satisfaction.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×